Delivery Order SPE2DP26D0003-SPE2DP26F1179
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $1,336,273.60, is for the delivery of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
- This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- This is a $87,130.68 firm fixed price purchase order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc. for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 29, 2021 and does not have a set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides vaccines, pharmaceuticals, and medical supplies to federal agencies. The company holds several indefinite delivery vehicles (IDVs) with agencies...
- This firm fixed price purchase order was awarded to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical products, to provide influenza virus vaccines to the Medical Supply Chain, a component of the Defense Logistics Agency. The $1,548.18 contract has a completion date of September 30, 2024 and is not associated with any set-aside designation. Sanofi Pasteur Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the...
- This is a $2,682,187.20 firm fixed price delivery order awarded to Sanofi Pasteur Inc. by the Defense Logistics Agency (DLA) to provide Influenza Virus Vaccines. The award has an ultimate completion date of October 11, 2024 and is not associated with a set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical goods that holds several indefinite delivery vehicles (IDVs) with the Department of Health and Human Services, Centers for Disease Control and...
- This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The contract is for the delivery of influenza virus vaccines, with an ultimate completion date of September 26, 2025 and a ceiling value of $2,317,562.40. The contract is a Firm Fixed Price (FFP) contract and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies, for the provision of influenza virus vaccines. The contract has a ceiling value of $983,915.20 and is a firm fixed price delivery order, with an ultimate completion date of September 26, 2025. The contract is awarded by the Defense Logistics Agency, a component of the Department of Defense, and is not set aside for any specific business category....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, for the provision of influenza virus vaccines. The contract has a ceiling value of $2,794,325.82 and a period of performance through November 15, 2016. Sanofi Pasteur Inc. has been awarded numerous indefinite delivery vehicles (IDVs) from various federal agencies, including a $5.87 billion IDIQ from the HHS Office of the Assistant Secretary for...
- Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, has been awarded a firm fixed price Delivery Order contract by the Defense Logistics Agency Troop Support Medical for $2,650.81 to provide influenza virus vaccines. The contract has a completion date of March 29, 2024. This award is not associated with a set-aside program. Sanofi Pasteur Inc. is a major supplier of vaccines and pharmaceuticals to various U.S. government agencies, including the Department of Veterans Affairs, Centers...
- This is a firm fixed price purchase order awarded by the Defense Logistics Agency Troop Support Medical to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of vaccines and pharmaceuticals. The $100,810 contract is for the provision of influenza virus vaccine, with a completion date of September 15, 2020. The award does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines, pharmaceuticals, and medical supplies to various U.S. government agencies,...
- SPE2DP26D0003Indefinite Delivery Contract
- SPE2DP26D0003-SPE2DP26F1179Delivery Order
The U.S. Department of Defense Medical Supply Chain awarded a $486,741.33 firm fixed-price delivery order to Sanofi Vaccines US Inc. (division of Sanofi Pasteur Inc.) on December 12, 2025, for the procurement of influenza virus vaccine. The contract, which carries no set-aside designation, is scheduled for completion by March 31, 2026, and will be performed at the contractor's facility in Swiftwater, Pennsylvania. Sanofi Pasteur Inc. is a foreign-owned pharmaceutical manufacturer and established critical supplier of vaccines to multiple federal agencies, including the Department of Defense, Department of Health and Human Services, Centers for Disease Control and Prevention, and Department of Veterans Affairs. This delivery order aligns with the Department of Defense's ongoing immunization requirements and draws from Sanofi Pasteur's extensive portfolio of vaccine contracts across federal agencies. The contractor holds several significant indefinite delivery contracts with the CDC for vaccine procurement, including contracts valued up to $2.196 billion for the Vaccines for Children program and multiple influenza vaccine contracts ranging from $15 million to $47.5 million. The firm fixed-price structure provides cost certainty for this influenza vaccine procurement, supporting the department's personnel immunization and pandemic preparedness objectives through a vendor with a demonstrated track record of fulfilling large-scale federal vaccine supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $486.7k | 12/11/25 |